Literature DB >> 25444405

Raltegravir and rifampicin in patients with HIV and tuberculosis.

Sandor Klis1, Alper Daskapan2, Onno W Akkerman3, Jan-Willem Alffenaar2, Ymkje Stienstra4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25444405     DOI： 10.1016/S1473-3099(14)70977-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios.

Authors:  Hannah Yejin Kim; Kenneth C Byashalira; Scott K Heysell; Anne-Grete Märtson; Stellah G Mpagama; Prakruti Rao; Marieke G G Sturkenboom; Jan-Willem C Alffenaar
Journal:  Ther Drug Monit       Date:  2022-02-01       Impact factor: 3.118

Review 2.  Tuberculosis and HIV-An Update on the "Cursed Duet" in Children.

Authors:  Samantha H-L Fry; Shaun L Barnabas; Mark F Cotton
Journal:  Front Pediatr       Date:  2019-04-25       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.